{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:07:07Z","timestamp":1784592427093,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16244-3","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T01:37:11Z","timestamp":1779759431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of TIE-2 levels in newly diagnosed and untreated multiple myeloma patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Bilal","family":"Ayg\u00fcn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep Tu\u011fba","family":"Karabulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Suyan\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Bankir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didar Yanarda\u011f","family":"A\u00e7\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"16244_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-021-01162-7","volume":"14","author":"CT Wallington-Beddoe","year":"2021","unstructured":"Wallington-Beddoe CT, Mynott RL. Prognostic and predictive biomarker developments in multiple myeloma. J Hematol Oncol. 2021;14:1\u201315.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"16244_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.cardiores.2006.08.002","volume":"72","author":"KL Kim","year":"2006","unstructured":"Kim KL, Shin I-S, Kim J-M, Choi J-H, Byun J, Jeon E-S, et al. Interaction between Tie receptors modulates angiogenic activity of angiopoietin2 in endothelial progenitor cells. Cardiovascular Res. 2006;72(3):394\u2013402.","journal-title":"Cardiovascular Res"},{"issue":"19","key":"16244_CR3","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1002\/1873-3468.13568","volume":"593","author":"FF He","year":"2019","unstructured":"He FF, Zhang D, Chen Q, Zhao Y, Wu L, Li ZQ, et al. Angiopoietin-Tie signaling in kidney diseases: an updated review. FEBS Lett. 2019;593(19):2706\u201315.","journal-title":"FEBS Lett"},{"issue":"3","key":"16244_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrm2639","volume":"10","author":"HG Augustin","year":"2009","unstructured":"Augustin HG, Young Koh G, Thurston G, Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin\u2013Tie system. Nat Rev Mol Cell Biol. 2009;10(3):165\u201377.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"16244_CR5","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1158\/1541-7786.MCR-07-0072","volume":"5","author":"WS Shim","year":"2007","unstructured":"Shim WS, Ho IA, Wong PE. Angiopoietin: a TIE (d) balance in tumor angiogenesis. Mol Cancer Res. 2007;5(7):655\u201365.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"16244_CR6","first-page":"305","volume":"18","author":"H Osada","year":"2001","unstructured":"Osada H, Tokunaga T, Hatanaka H, Kawakami T, Tsuchida T, Abe Y, et al. Gene expression of angiogenesis related factors in glioma. Int J Oncol. 2001;18(2):305\u20139.","journal-title":"Int J Oncol"},{"issue":"5","key":"16244_CR7","first-page":"1287","volume":"7","author":"H Hatanaka","year":"2001","unstructured":"Hatanaka H, Abe Y, Naruke M, Tokunaga T, Oshika Y, Kawakami T, et al. Significant correlation between interleukin 10 expression and vascularization through angiopoietin\/TIE2 networks in non-small cell lung cancer. Clin Cancer Res. 2001;7(5):1287\u201392.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"16244_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3324\/haematol.11852","volume":"93","author":"K Anargyrou","year":"2008","unstructured":"Anargyrou K, Terpos E, Vassilakopoulos TP, Pouli A, Sachanas S, Tzenou T, et al. Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory\/resistant multiple myeloma patients treated with bortezomib. Haematologica. 2008;93(3):451\u20134.","journal-title":"Haematologica"},{"issue":"1","key":"16244_CR9","first-page":"113","volume":"88","author":"S Uneda","year":"2003","unstructured":"Uneda S, Matsuno F, Sonoki T, Tniguchi I, Kawano F, Hata H. Expressions of vascular endothelial growth factor and angiopoietin-2 in myeloma cells. Haematologica. 2003;88(1):113\u20135.","journal-title":"Haematologica"},{"issue":"3","key":"16244_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2141.1994.tb08304.x","volume":"87","author":"A Vacca","year":"1994","unstructured":"Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol. 1994;87(3):503\u20138.","journal-title":"Br J Haematol"},{"issue":"2","key":"16244_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/onco5020021","volume":"5","author":"P Spiliopoulou","year":"2025","unstructured":"Spiliopoulou P, Rousakis P, Panteli C, Eleutherakis-Papaiakovou E, Migkou M, Kanellias N, et al. The role of the bone marrow microenvironment in physical function and quality of life in patients with multiple myeloma after first-line treatment with novel agents and autologous transplantation. Onco. 2025;5(2):21.","journal-title":"Onco"},{"issue":"15","key":"16244_CR12","doi-asserted-by":"publisher","first-page":"7301","DOI":"10.3390\/ijms26157301","volume":"26","author":"A Agafonova","year":"2025","unstructured":"Agafonova A, Prinzi C, Trovato Salinaro A, Ledda C, Cosentino A, Cambria MT, et al. Breaking barriers: the role of the bone marrow microenvironment in multiple myeloma progression. Int J Mol Sci. 2025;26(15):7301.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"16244_CR13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrd.2016.278","volume":"16","author":"P Saharinen","year":"2017","unstructured":"Saharinen P, Eklund L, Alitalo K. Therapeutic targeting of the angiopoietin\u2013TIE pathway. Nat Rev Drug Discovery. 2017;16(9):635\u201361.","journal-title":"Nat Rev Drug Discovery"},{"issue":"2","key":"16244_CR14","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1182\/blood-2002-10-3257","volume":"102","author":"N Giuliani","year":"2003","unstructured":"Giuliani N, Colla S, Lazzaretti M, Sala R, Roti G, Mancini C, et al. Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis. Blood. 2003;102(2):638\u201345.","journal-title":"Blood"},{"key":"16244_CR15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/978-94-017-8035-3_2","volume-title":"Angiogenesis in Multiple Myeloma. Angiogenesis and Anti-Angiogenesis in Hematological Malignancies","author":"D Ribatti","year":"2014","unstructured":"Ribatti D. Angiogenesis in Multiple Myeloma. Angiogenesis and Anti-Angiogenesis in Hematological Malignancies. Springer; 2014. pp. 7\u201333."},{"issue":"22","key":"16244_CR16","doi-asserted-by":"publisher","first-page":"12047","DOI":"10.3390\/ijms252212047","volume":"25","author":"F Garbicz","year":"2024","unstructured":"Garbicz F, Kaszkowiak M, Dudkiewicz-Garbicz J, Dorfman DM, Ostrowska J, Barankiewicz J, et al. Characterization and experimental use of multiple myeloma bone marrow endothelial cells and progenitors. Int J Mol Sci. 2024;25(22):12047.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"16244_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc.2017.51","volume":"17","author":"M De Palma","year":"2017","unstructured":"De Palma M, Biziato D, Petrova TV. Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer. 2017;17(8):457\u201374.","journal-title":"Nat Rev Cancer"},{"issue":"14","key":"16244_CR18","doi-asserted-by":"publisher","first-page":"7470","DOI":"10.3390\/ijms22147470","volume":"22","author":"AM Soliman","year":"2021","unstructured":"Soliman AM, Das S, Teoh SL. Next-generation biomarkers in multiple myeloma: understanding the molecular basis for potential use in diagnosis and prognosis. Int J Mol Sci. 2021;22(14):7470.","journal-title":"Int J Mol Sci"},{"issue":"24","key":"16244_CR19","doi-asserted-by":"publisher","first-page":"13404","DOI":"10.3390\/ijms252413404","volume":"25","author":"YA Veryaskina","year":"2024","unstructured":"Veryaskina YA, Titov SE, Skvortsova NV, Kovynev IB, Antonenko OV, Demakov SA, et al. Multiple myeloma: genetic and epigenetic biomarkers with clinical potential. Int J Mol Sci. 2024;25(24):13404.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"16244_CR20","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1186\/s12885-024-13024-9","volume":"24","author":"R Hu","year":"2024","unstructured":"Hu R, Chen F, Yu X, Li Z, Li Y, Feng S, et al. Construction and validation of a prognostic model of angiogenesis-related genes in multiple myeloma. BMC Cancer. 2024;24(1):1269.","journal-title":"BMC Cancer"},{"key":"16244_CR21","doi-asserted-by":"publisher","first-page":"973836","DOI":"10.3389\/fonc.2022.973836","volume":"12","author":"AG Solimando","year":"2022","unstructured":"Solimando AG, Malerba E, Leone P, Prete M, Terragna C, Cavo M, et al. Drug resistance in multiple myeloma: soldiers and weapons in the bone marrow niche. Front Oncol. 2022;12:973836.","journal-title":"Front Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16244-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16244-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16244-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:38:53Z","timestamp":1784590733000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16244-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16244"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16244-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Adana City Training and Research Hospital (2556\/2023). Written informed consent was obtained from all participants prior to enrollment.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"873"}}